AI company matching patients with clinical trials using digital pathology. $31.2M funded. Focuses on oncology trial recruitment through AI-powered pathology analysis.
Vendor description
AI-powered pathology-based patient matching for oncology trials
Oncology patient matching,Pathology-based screening,AI trial recruitment
- Unique AI pathology approach
- Oncology specialism
- $31.2M funded
- Digital pathology integration
- Oncology only
- Early-stage company
- Limited therapeutic breadth
Approved customer reviews
Write a reviewNo reviews yet
Be the first customer to share verified experience with this vendor.
Pricing
$
Key facts
| HQ country | United States |
|---|---|
| Geography | North America |
| Service model | SaaS |
| Study phases | Phase I, Phase II, Phase III |
| Trial scale | Small,Medium |
| Therapeutic areas | Oncology |
Related vendors
Editorial ranking
See how Deep Lens compares - best AI / Machine Learning vendors for clinical trials.